ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6,101 | 66.16595 | 1 | female | 0 | 10 | 890 | Colon Cancer | Cancer | 1 | null | null | 0 | 13,752 | 10,945.625 | 10,203.4297 | 20 | white | 16.398438 | 16 | 0.822998 | 0.616943 | 1 | 0 | 0 | metastatic | 1 | 0.8 | no dnr | 10 | 106 | 12.298828 | 106 | 20 | 36.19531 | null | 2.199707 | 0.5 | 0.699951 | 135 | null | null | null | null | null | null | null | 2.678711 |
6,102 | 74.02295 | 1 | female | 1 | 5 | 5 | CHF | COPD/CHF/Cirrhosis | 3 | null | under $11k | 0 | 20,338 | 17,173.6562 | 16,354.0391 | 11 | white | 25.097656 | 22 | 0.697998 | 0.533936 | 9 | 0 | 0 | no | null | null | dnr after sadm | 2 | 61 | 16.097656 | 54 | 22 | 34.89844 | null | null | null | 0.799927 | 131 | null | null | null | null | null | null | <2 mo. follow-up | 2.818848 |
6,103 | 77.62897 | 1 | female | 0 | 4 | 403 | Lung Cancer | Cancer | 3 | 12 | under $11k | 0 | 2,329 | 1,721.9814 | 486.50977 | 10 | white | 12.798828 | 24 | 0.757935 | 0.50293 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 63 | 3.899902 | 86 | 28 | 36.19531 | 296 | 3.899902 | 0.299988 | 0.699951 | 136 | 7.389648 | null | null | null | null | null | null | 2.87793 |
6,104 | 63.159 | 1 | male | 0 | 10 | 114 | Lung Cancer | Cancer | 3 | 2 | under $11k | 0 | 6,314 | 4,904.9883 | 4,245.51953 | 5.5 | white | 22.796875 | 14 | 0.580933 | 0.260986 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | dnr after sadm | 8 | 65 | 7 | 94 | 21 | 36.09375 | null | 3.199707 | 0.5 | 0.799927 | 130 | null | null | null | null | 4 | 6 | no(M2 and SIP pres) | 6 |
6,105 | 61.95999 | 0 | female | 0 | 8 | 1,810 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 14,632 | 12,260.9844 | 11,042.5781 | 16.5 | white | 30.296875 | 28 | 0.713989 | 0.62793 | 1 | 0 | 0 | no | 0.9 | 0.85 | dnr after sadm | 4 | 72 | 3.399902 | 118 | 32 | 36.79688 | 520.875 | 2.599609 | 0.299988 | 0.099991 | 135 | 7.389648 | null | null | null | 6 | 6 | adl>=4 (>=5 if sur) | 6 |
6,106 | 74.38696 | 1 | female | 1 | 11 | 11 | MOSF w/Malig | ARF/MOSF | 3 | 12 | under $11k | 9 | 11,969 | 8,219.4922 | 8,524.78906 | 32 | white | 37.195313 | 54 | 0.200989 | 0.107986 | 1 | 0 | 0 | metastatic | 0.5 | 0.5 | no dnr | 11 | 110 | 0 | 108 | 30 | 36 | null | 2 | 1.099854 | 1.799805 | 127 | null | null | null | null | 7 | 6 | <2 mo. follow-up | 6 |
6,107 | 53.46997 | 1 | male | 1 | 31 | 31 | Lung Cancer | Cancer | 1 | 13 | $25-$50k | 100 | 64,508 | 45,421.3438 | 47,679.9688 | 40 | other | 18.398438 | 16 | 0.190979 | 0.016998 | 3 | 0 | 0 | metastatic | 0.2 | 0.1 | dnr after sadm | 15 | 142 | 11 | 68 | 10 | 38.19531 | 300 | 3.099609 | 0.799927 | 0.899902 | 138 | 7.5 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
6,108 | 64.31995 | 1 | female | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 7 | under $11k | 44 | 49,996 | 34,270.7188 | 34,682.0312 | 58.5 | black | 31.398438 | 51 | 0.376953 | 0.258972 | 11 | 0 | 0 | no | 0.25 | 0.25 | dnr after sadm | 10 | 47 | 28 | 79 | 8 | 35.39844 | 166 | 2.399902 | 0.799927 | 1.299805 | 134 | 7.319336 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
6,109 | 25.56899 | 0 | female | 0 | 8 | 1,808 | CHF | COPD/CHF/Cirrhosis | 2 | 11 | under $11k | 0 | 10,774 | 8,177.8164 | 8,215.79688 | 14.5 | white | 21.898438 | 27 | 0.919922 | 0.865967 | 3 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 8 | 106 | 11.099609 | 113 | 26 | 37.5 | null | null | 2.199707 | 1.299805 | 136 | null | null | null | null | 3 | 2 | no(M2 and SIP pres) | 2 |
6,110 | 90.79297 | 0 | female | 0 | 5 | 1,806 | CHF | COPD/CHF/Cirrhosis | 4 | 10 | under $11k | 0 | 3,583 | 2,672.3301 | 2,389.16992 | 15 | black | 18 | 31 | 0.751953 | 0.608887 | 1 | 0 | 0 | yes | 0.9 | 0.8 | dnr after sadm | 4 | 114 | 5.599609 | 104 | 24 | 36.39844 | 285.6875 | null | 0.399963 | 1.399902 | 136 | 7.289062 | null | null | null | 3 | 1 | no(M2 and SIP pres) | 1 |
6,111 | 49.34198 | 0 | female | 0 | 14 | 1,807 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | >$50k | 9 | 21,761 | 16,395.3594 | 15,894.8984 | 25.666656 | white | 34 | 68 | 0.666992 | 0.570923 | 1 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 14 | 115 | 19 | 75 | 32 | 35.79688 | 208 | 2.699707 | 19.597656 | 7.399414 | 138 | 7.269531 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
6,112 | 28.674 | 1 | male | 0 | 42 | 122 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 0 | under $11k | 44 | 41,966 | 31,984.6875 | 30,799.4219 | 30 | black | 23.597656 | 25 | 0.823975 | 0.764893 | 1 | 0 | 0 | no | 0.2 | 0.05 | no dnr | 42 | 71 | 15.398438 | 113 | 28 | 39.09375 | 223.96875 | 2.599609 | 2.899902 | 0.799927 | 136 | 7.399414 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.799805 |
6,113 | 40.67398 | 0 | male | 0 | 18 | 1,805 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 32,228 | 26,405.9688 | 24,254.6562 | 25 | white | 29.5 | 44 | 0.81189 | 0.748901 | 1 | 0 | 0 | no | 0.5 | 0.45 | no dnr | 18 | 81 | 18.5 | 104 | 32 | 38.19531 | 118.32812 | 2.799805 | 1 | 8.898438 | 137 | 7.289062 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,114 | 61.20499 | 0 | male | 0 | 21 | 1,805 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | under $11k | 0 | 24,785 | 19,240.0938 | 19,142.0781 | 22.666656 | white | 35.695313 | 53 | 0.5979 | 0.48999 | 1 | 0 | 0 | no | 0.75 | 0.6 | dnr after sadm | 14 | 75 | 17.097656 | 120 | 24 | 36.39844 | 149.96875 | 2.799805 | 17.296875 | 0.699951 | 136 | 7.439453 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
6,115 | 78.25897 | 1 | female | 1 | 9 | 9 | COPD | COPD/CHF/Cirrhosis | 1 | null | under $11k | 0 | 24,767 | 20,170.4375 | 18,509.7188 | 43 | white | 34.59375 | 73 | 0.470947 | 0.268982 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 9 | 67 | 27.5 | 172 | 40 | 37.89844 | 145 | 2.899902 | 0.699951 | 1.099854 | 135 | 7.199219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,116 | 57.10098 | 1 | female | 1 | 9 | 9 | MOSF w/Malig | ARF/MOSF | 1 | 10 | null | 37 | 15,277 | 10,335.9844 | 10,889.4688 | 22 | white | 28.597656 | 20 | 0.266968 | 0.16098 | 5 | 0 | 0 | metastatic | 0.5 | 0.5 | dnr after sadm | 1 | 68 | 12.699219 | 68 | 22 | 36.19531 | 169.5625 | 3.099609 | 0.799927 | 0.399963 | 127 | 7.459961 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
6,117 | 70.67798 | 1 | male | 0 | 15 | 82 | COPD | COPD/CHF/Cirrhosis | 5 | 10 | under $11k | 0 | 27,689 | 22,611.8906 | 20,786.0781 | 28.333328 | white | 26.199219 | 30 | 0.688965 | 0.522949 | 1 | 0 | 0 | yes | 0.4 | 0.35 | no dnr | 15 | 128 | 11.099609 | 136 | 36 | 38.29688 | 323.3125 | 2.799805 | 0.599976 | 0.599976 | 130 | 7.40918 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
6,118 | 76.13397 | 0 | male | 0 | 21 | 1,803 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | $11-$25k | 0 | 25,041 | 19,356.9375 | 17,746.7656 | 17 | white | 24.796875 | 37 | 0.728882 | 0.575928 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 21 | 106 | 23.398438 | 109 | 8 | 37.89844 | 61.09375 | 4.299805 | 1 | 1.299805 | 136 | 7.219727 | null | null | null | null | null | adl>=4 (>=5 if sur) | 3.283203 |
6,119 | 42.034 | 1 | male | 0 | 21 | 451 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 21,258 | 16,261.6641 | 15,196.5391 | 17 | black | 30.699219 | 42 | 0.721924 | 0.566895 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 21 | 82 | 30 | 122 | 26 | 37.79688 | 476 | 2.699707 | 7.599609 | 0.5 | 143 | 7.329102 | null | null | null | null | 7 | no(M2 and SIP pres) | 7 |
6,120 | 61.69998 | 1 | male | 0 | 6 | 12 | Lung Cancer | Cancer | 3 | 4 | under $11k | 0 | 5,497 | 3,823.4199 | 3,962.20898 | 14 | black | 24.699219 | 29 | 0.535889 | 0.213989 | 1 | 0 | 0 | metastatic | 0.5 | 0.4 | dnr after sadm | 2 | 93 | 15.298828 | 112 | 24 | 37.5 | 233.3125 | 3.599609 | 0.599976 | 0.5 | 127 | 7.40918 | null | null | null | 6 | 5 | <2 mo. follow-up | 5 |
6,121 | 34.21997 | 0 | female | 0 | 20 | 1,801 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 26,755 | 21,557.2812 | 19,361.2656 | 28 | black | 26.699219 | 54 | 0.863892 | 0.815918 | 1 | 1 | 0 | no | 0.7 | 0.65 | no dnr | 20 | 107 | 14 | 154 | 20 | 38.5 | 321.625 | 2.899902 | 0.899902 | 5 | 143 | 7.289062 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,122 | 48.71198 | 1 | male | 0 | 52 | 942 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 0 | 80,965 | 60,449.4688 | 60,074.0938 | 39.25 | black | 28.296875 | 60 | 0.494995 | 0.376953 | 4 | 0 | 0 | metastatic | 0.35 | 0.3 | no dnr | 52 | 63 | 16.898438 | 141 | 48 | 39.69531 | 308.5625 | 2.399902 | 0.399963 | 2.099609 | 135 | 7.25 | null | null | null | null | null | Coma or Intub | 3.120117 |
6,123 | 37.66699 | 0 | male | 0 | 10 | 1,798 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 7 | under $11k | 0 | 8,869 | 6,339.2773 | 6,359.57812 | 14 | white | 20.699219 | 21 | 0.907959 | 0.875 | 1 | 0 | 0 | no | 0.98 | 0.95 | no dnr | 10 | 103 | 10.099609 | 106 | 26 | 37.39844 | 240 | 2.5 | 0.5 | 0.5 | 140 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,124 | 80.40198 | 1 | female | 0 | 14 | 1,598 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | under $11k | 0 | 19,842 | 15,220.7266 | 14,714.0547 | 31.333328 | white | 20.199219 | 32 | 0.80896 | 0.744995 | 1 | 1 | 0 | no | 0.5 | 0.3 | no dnr | 14 | 101 | 9.699219 | 69 | 30 | 36 | 367.125 | 4 | 0.599976 | 1.399902 | 132 | 7.339844 | null | null | null | 1 | 2 | no(M2 and SIP pres) | 2 |
6,125 | 54.58197 | 1 | male | 0 | 28 | 788 | CHF | COPD/CHF/Cirrhosis | 5 | 10 | under $11k | 0 | 35,406 | 16,886.2656 | 15,097.5234 | 16.25 | white | 28.296875 | 34 | 0.792969 | 0.666992 | 1 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 28 | 69 | 14.099609 | 115 | 24 | 35 | 289 | 2.5 | 1.299805 | 1.399902 | 134 | 7.40918 | null | null | null | 1 | null | null | 1.1669 |
6,126 | 60.28198 | 1 | male | 1 | 4 | 4 | Coma | Coma | 1 | 12 | null | 61 | 8,966 | 6,013.7773 | 6,082.54688 | 25 | white | 25.398438 | 29 | 0.385986 | 0.312988 | 2 | 0 | 0 | no | 0.03 | 0.000027 | dnr after sadm | 2 | 114 | 17.398438 | 57 | 8 | 38 | 102.84375 | null | null | 1.5 | 137 | 7.55957 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,127 | 78.23096 | 0 | female | 0 | 14 | 1,796 | Lung Cancer | Cancer | 4 | 8 | under $11k | 0 | 13,297 | 9,301.0312 | 10,425.2969 | 14.333328 | white | 20.296875 | 34 | 0.599976 | 0.281982 | 1 | 1 | 0 | metastatic | 0.8 | 0.7 | no dnr | 14 | 117 | 11.5 | 74 | 30 | 39.09375 | 274.25 | 2.699707 | 0.97998 | 0.699951 | 134 | 7.40918 | null | null | null | 2 | 1 | no(M2 and SIP pres) | 1 |
6,128 | 63.461 | 1 | female | 0 | 7 | 39 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 8 | under $11k | 37 | 13,104 | 11,109.5781 | 10,091.5859 | 23 | black | 31.796875 | 60 | 0.512939 | 0.396973 | 1 | 1 | 0 | no | 0.7 | 0.5 | dnr after sadm | 1 | 61 | 25.796875 | 107 | 36 | 36.19531 | 355.5 | 2.199707 | 1.599854 | 11.298828 | 125 | 7.379883 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
6,129 | 46.03699 | 1 | male | 1 | 27 | 27 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 93,619 | 64,251.2812 | 64,284 | 51.75 | white | 26.5 | 47 | 0.799927 | 0.733887 | 5 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 27 | 111 | 4.399414 | 108 | 14 | 37.59375 | 191 | 1.899902 | 0.699951 | 2.099609 | 134 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 2.671875 |
6,130 | 70.44995 | 1 | female | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 11 | $11-$25k | 26 | 13,830 | 10,619.9219 | 9,923.04688 | 23.5 | white | 28.699219 | 55 | 0.603882 | 0.496948 | 1 | 1 | 1 | no | 0.8 | 0.6 | dnr after sadm | 4 | 126 | 22 | 130 | 24 | 37.59375 | 480.9375 | 2.199707 | 2.599609 | 3.699707 | 141 | 7.399414 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
6,131 | 60.93399 | 0 | female | 0 | 5 | 1,792 | CHF | COPD/CHF/Cirrhosis | 3 | 7 | under $11k | 0 | 4,762 | 3,383.1133 | 2,993.99805 | 13 | hispanic | 17.398438 | 26 | 0.895996 | 0.825928 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 5 | 74 | 10.199219 | 100 | 16 | 36.09375 | 409.5 | 3.699707 | 0.799927 | 1.299805 | 137 | 7.429688 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
6,132 | 38.32397 | 1 | female | 0 | 12 | 683 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 27,923 | 21,899.0938 | 21,813.3438 | 48 | white | 29.097656 | 43 | 0.823975 | 0.764893 | 1 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 12 | 120 | null | 114 | 40 | 38.09375 | 111.65625 | 2.699707 | 4.099609 | 0.899902 | 137 | 7.459961 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,133 | 51.72098 | 1 | male | 0 | 37 | 274 | MOSF w/Malig | ARF/MOSF | 2 | 11 | $11-$25k | 61 | 71,184 | 55,309.4375 | 54,298 | 36.75 | black | 43.195313 | 107 | 0.021999 | 0.004999 | 1 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 8 | 55 | 0.119995 | 164 | 58 | 38.5 | 205 | 2.799805 | 0.599976 | 5.099609 | 133 | 7.299805 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,134 | 46.60098 | 1 | male | 0 | 9 | 745 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 6,502 | 4,792.9609 | 4,722.82812 | 7.5 | white | 32 | 43 | 0.659912 | 0.483948 | 1 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 9 | 83 | 8.699219 | 120 | 24 | 39.79688 | 314.25 | 2.399902 | 23.199219 | 1 | 129 | 7.489258 | null | null | null | 0 | 2 | SIP>=30 | 2 |
6,135 | 71.39795 | 1 | female | 1 | 3 | 3 | Coma | Coma | 1 | 8 | null | 100 | 9,371 | 7,837.5391 | 7,230.20703 | 37 | white | 29.199219 | 72 | 0.043999 | 0.021999 | 2 | 0 | 0 | no | 0 | 0 | dnr after sadm | 2 | 141 | 30.5 | 167 | 0 | 35.79688 | 375.5 | null | 1 | 0.799927 | 140 | 7.339844 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,136 | 50.98999 | 1 | male | 0 | 18 | 695 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 26 | 35,167 | 26,106.5469 | 26,240.1562 | 15 | black | 16.699219 | 26 | 0.760986 | 0.620972 | 15 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 18 | 120 | 5.899414 | 81 | 24 | 36.79688 | 380.9375 | 2.399902 | 2.5 | 0.599976 | 141 | 7.489258 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
6,137 | 64.97998 | 1 | female | 0 | 51 | 82 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 9 | under $11k | 0 | 79,752 | 61,106.6562 | 66,229.375 | 33.5 | black | 30.796875 | 67 | 0.588989 | 0.480957 | 22 | 1 | 0 | no | 0.5 | 0.4 | no dnr | 51 | 151 | 8.699219 | 122 | 48 | 35.79688 | null | 2.799805 | 3.599609 | 2.599609 | 142 | 7.379883 | null | null | null | null | 6 | null | 6 |
6,138 | 60.44098 | 1 | male | 0 | 142 | 435 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | under $11k | 89 | 215,368 | 147,888.75 | 153,348.625 | 47.25 | white | 21.699219 | 40 | 0.55896 | 0.44696 | 1 | 1 | 0 | no | 0.01 | 0.000001 | no dnr | 142 | 61 | 17.898438 | 66 | 10 | 38.09375 | 150 | 1.599854 | 0.5 | 1.799805 | 142 | 7.30957 | null | null | null | null | null | adl>=4 (>=5 if sur) | 4.3125 |
6,139 | 29.37199 | 0 | female | 0 | 4 | 1,788 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 8,842 | 7,442.1211 | 7,271.27734 | 36 | white | 30.199219 | 39 | 0.836914 | 0.780884 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 76 | 8.5 | 64 | 44 | 36.19531 | 206.65625 | 2.399902 | 3.299805 | 0.5 | 124 | 7.439453 | null | null | null | 5 | null | SIP>=30 | 3.855299 |
6,140 | 56.77499 | 1 | female | 0 | 7 | 478 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 55 | 11,870 | 9,637.2969 | 9,996.03906 | 25 | hispanic | 30.699219 | 49 | 0.498962 | 0.381958 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 63 | 10.898438 | 120 | 12 | 35.5 | 576 | 3.399902 | 1.699951 | 2.5 | 139 | 7.40918 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
6,141 | 38.51297 | 1 | male | 0 | 5 | 1,265 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 3,277 | 2,470.75 | 2,119 | 6 | black | 24.097656 | 18 | 0.890991 | 0.817993 | 1 | 0 | 0 | no | 1 | 0.95 | no dnr | 5 | 83 | 11.199219 | 78 | 28 | 35.39844 | null | 3.099609 | 0.799927 | 1.099854 | 134 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,142 | 60.504 | 0 | female | 0 | 6 | 1,786 | CHF | COPD/CHF/Cirrhosis | 3 | 10 | under $11k | 0 | 4,814 | 3,455.4551 | 3,256.42969 | 4 | black | 10.398438 | 16 | 0.939941 | 0.897949 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 6 | 63 | 5 | 76 | 22 | 37 | 317.5625 | 4 | 0.5 | 0.799927 | 141 | 7.389648 | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 |
6,143 | 66.89697 | 0 | female | 0 | 11 | 1,783 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 1 | under $11k | 0 | 9,648 | 7,119.8281 | 7,129.34766 | 8.5 | white | 29.699219 | 23 | 0.702881 | 0.613892 | 1 | 1 | 0 | no | 0.85 | 0.7 | no dnr | 11 | 107 | 9.398438 | 55 | 22 | 35.59375 | 390.75 | 3.299805 | 2 | 0.5 | 123 | 7.429688 | null | null | null | 1 | 0 | null | 0 |
6,144 | 77.20496 | 1 | male | 0 | 15 | 139 | MOSF w/Malig | ARF/MOSF | 4 | 9 | under $11k | 9 | 17,320 | 13,018.6016 | 12,415.1172 | 10.666664 | white | 26 | 33 | 0.491943 | 0.373962 | 2 | 0 | 1 | metastatic | 0.7 | 0.5 | no dnr | 15 | 101 | 5 | 60 | 22 | 36 | null | null | null | 2.099609 | 131 | null | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
6,145 | 65.19397 | 1 | male | 1 | 52 | 52 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 11 | null | 9 | 95,928 | 149,235.375 | 145,356.375 | 49.75 | white | 32.898438 | 76 | 0.549927 | 0.436951 | 4 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 31 | 140 | 7.799805 | 160 | 50 | 38.39844 | 66.65625 | 2.599609 | 2.099609 | 1.399902 | 138 | 7.359375 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,146 | 58.71597 | 1 | male | 0 | 7 | 409 | CHF | COPD/CHF/Cirrhosis | 7 | 9 | under $11k | 0 | 5,241 | 3,779.2324 | 3,529.80859 | 6 | white | 11.898438 | 13 | 0.934937 | 0.889893 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 7 | 117 | 11.398438 | 76 | 24 | 35.79688 | 345.6875 | 4.299805 | 0.5 | 1.199951 | 137 | 7.359375 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,147 | 39.53998 | 1 | male | 0 | 15 | 137 | MOSF w/Malig | ARF/MOSF | 3 | 12 | under $11k | 0 | 14,958 | 10,852.5078 | 11,143.5547 | 12.666664 | black | 26.199219 | 44 | 0.640991 | 0.539917 | 4 | 0 | 0 | yes | 1 | 0.95 | no dnr | 15 | 68 | 0.799927 | 110 | 28 | 38.59375 | null | 3.199707 | 0.699951 | 1.099854 | 136 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
6,148 | 77.09198 | 1 | male | 0 | 12 | 228 | Colon Cancer | Cancer | 1 | null | null | 0 | 8,254 | 6,119.1133 | 6,220.46875 | 17.5 | white | 14.398438 | 27 | 0.829956 | 0.628906 | 1 | 0 | 0 | metastatic | 0.85 | 0.7 | no dnr | 12 | 76 | 1.5 | 72 | 20 | 36.5 | null | 3.599609 | 1.299805 | 1.399902 | 137 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.811523 |
6,149 | 63.35397 | 1 | female | 0 | 6 | 570 | Lung Cancer | Cancer | 2 | 12 | under $11k | 0 | 5,825 | 4,132.4453 | 4,908.55859 | 12 | white | 9.599609 | 16 | 0.829956 | 0.629883 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 6 | 95 | 18.597656 | 100 | 28 | 36.69531 | null | 4.399414 | 0.599976 | 0.799927 | 141 | null | null | null | null | 1 | 1 | SIP>=30 | 1 |
6,150 | 69.07898 | 1 | female | 1 | 30 | 30 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 10 | $11-$25k | 0 | 58,852 | 42,840.1562 | 43,494.8438 | 25.5 | white | 28.5 | 43 | 0.716919 | 0.629883 | 1 | 0 | 0 | no | 0.5 | 0.2 | dnr after sadm | 8 | 64 | 7.299805 | 116 | 24 | 35.19531 | 220 | 4.699219 | 0.799927 | 6.099609 | 135 | 7.319336 | null | null | null | null | null | <2 mo. follow-up | 3.978516 |
6,151 | 64.79095 | 0 | female | 0 | 25 | 1,778 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 25,943 | 19,867.2188 | 19,136.7656 | 17.5 | white | 19.296875 | 28 | 0.86499 | 0.816895 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 25 | 114 | 10 | 100 | 28 | 38.09375 | 188 | null | 0.5 | 1.299805 | 139 | 7.389648 | null | null | null | null | 4 | adl>=4 (>=5 if sur) | 4 |
6,152 | 40.54999 | 0 | male | 0 | 11 | 1,777 | Coma | Coma | 1 | 12 | $11-$25k | 9 | 31,993 | 23,123.7188 | 24,286.0938 | 25 | white | 18.398438 | 7 | 0.843994 | 0.81189 | 6 | 0 | 0 | no | 0.95 | 0.92 | no dnr | 11 | 107 | 13 | 57 | 12 | 36.79688 | 416.625 | 4.199219 | 0.799927 | 0.699951 | 137 | 7.419922 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,153 | 68.03296 | 1 | female | 1 | 62 | 62 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | under $11k | 0 | 152,535 | 108,015.625 | 105,496.688 | 51.25 | white | 30.199219 | 36 | 0.606934 | 0.500977 | 10 | 1 | 0 | no | 0.3 | 0.2 | dnr after sadm | 59 | 67 | 24.597656 | 130 | 36 | 36.5 | 161.40625 | null | null | 0.599976 | 136 | 7.489258 | null | null | null | 7 | null | null | 5.199497 |
6,154 | 65.23999 | 1 | female | 1 | 15 | 15 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 0 | 73,712 | 49,551.5 | 49,817.1875 | 46.666657 | white | 25.597656 | 52 | 0.574951 | 0.464966 | 17 | 0 | 0 | metastatic | 0.5 | 0.5 | dnr after sadm | 11 | 71 | 30.296875 | 116 | 28 | 36.89844 | 218.3125 | 1.899902 | 3.899902 | 0.899902 | 135 | 7.389648 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
6,155 | 80.383 | 1 | male | 1 | 14 | 14 | MOSF w/Malig | ARF/MOSF | 2 | 8 | null | 0 | 66,713 | 51,143.25 | 50,021.1875 | 58 | white | 40.796875 | 70 | 0.112991 | 0.048996 | 23 | 0 | 0 | yes | 0.8 | 0.6 | dnr after sadm | 11 | 64 | 2.399902 | 114 | 32 | 38.59375 | 114 | 2.299805 | 4.799805 | 2.799805 | 138 | 7.329102 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,156 | 79.79199 | 1 | female | 0 | 7 | 658 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 10,283 | 7,498.4453 | 7,438.09766 | 23 | black | 24 | 20 | 0.721924 | 0.636963 | 3 | 0 | 0 | no | 0.6 | 0.4 | no dnr | 7 | 101 | 11.798828 | 116 | 24 | 36.79688 | 321.1875 | 2.799805 | 0.5 | 0.599976 | 131 | 7.319336 | null | null | null | null | 6 | null | 6 |
6,157 | 40.93399 | 0 | female | 0 | 5 | 1,776 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 14 | $11-$25k | 0 | 8,101 | 6,421.1484 | 7,010.71875 | 16 | other | 19.597656 | 17 | 0.879883 | 0.799927 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 5 | 74 | 4 | 113 | 14 | 36.69531 | 595.125 | 3.399902 | 1.5 | 0.799927 | 135 | 7.509766 | null | null | null | 6 | 5 | no(M2 and SIP pres) | 5 |
6,158 | 32.50699 | 1 | male | 0 | 15 | 136 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 13 | $11-$25k | 0 | 13,892 | 10,281.625 | 9,194.67969 | 11 | white | 17.699219 | 14 | 0.917969 | 0.861938 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 15 | 93 | 4.899414 | 80 | 14 | 36 | null | 3.699707 | 2.399902 | 0.699951 | 140 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,159 | 58.40097 | 1 | female | 0 | 7 | 346 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 14 | under $11k | 0 | 5,292 | 3,863.125 | 3,674.46875 | 9 | white | 21.5 | 30 | 0.777954 | 0.644897 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 7 | 99 | 3.299805 | 80 | 20 | 36.19531 | null | 2.699707 | 0.699951 | 3.699707 | 135 | null | null | null | null | 1 | null | SIP>=30 | 1.1669 |
6,160 | 47.76498 | 0 | female | 0 | 7 | 1,774 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 9 | 7,541 | 5,135.9883 | 4,902.51953 | 17 | white | 25 | 35 | 0.839966 | 0.737915 | 1 | 0 | 0 | yes | null | null | no dnr | 7 | 77 | 14.699219 | 126 | 32 | 35.59375 | 168.5625 | null | 0.899902 | 0.799927 | 138 | 7.279297 | null | null | null | null | null | null | 3.236816 |
6,161 | 61.72498 | 1 | male | 0 | 6 | 1,177 | CHF | COPD/CHF/Cirrhosis | 4 | 11 | $25-$50k | 0 | 3,477 | 2,635.6445 | 2,312.25977 | 12 | white | 18.097656 | 13 | 0.888916 | 0.813965 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 99 | 6 | 68 | 24 | 35.59375 | 309.5 | 3.299805 | 1.299805 | 1.099854 | 141 | 7.389648 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.584473 |
6,162 | 36.99899 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 44 | 40,579 | 34,104.3125 | 31,750.1875 | 30.5 | white | 49.398438 | 65 | 0.076996 | 0.028 | 17 | 0 | 0 | no | 0 | 0 | dnr after sadm | 4 | 69 | 14.099609 | 111 | 23 | 38.39844 | 127.26562 | 3.699707 | 63 | 5.599609 | 139 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 2.939453 |
6,163 | 58.28897 | 1 | female | 0 | 8 | 25 | Lung Cancer | Cancer | 1 | 16 | under $11k | 0 | 6,811 | 5,021.3906 | 4,500.87891 | 4.5 | white | 17.296875 | 18 | 0.717896 | 0.439941 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | dnr after sadm | 4 | 67 | 5.199219 | 106 | 16 | 38.19531 | null | 3.899902 | 1 | 0.399963 | 130 | null | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
6,164 | 86.72998 | 0 | female | 0 | 18 | 1,772 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 0 | 19,233 | 15,117.0859 | 14,232.8672 | 26 | white | 31.699219 | 44 | 0.461975 | 0.342957 | 1 | 0 | 0 | yes | 0.8 | 0.8 | no dnr | 18 | 71 | 5 | 141 | 28 | 38.69531 | 220 | 2.899902 | 0.399963 | 0.399963 | 125 | 7.429688 | null | null | null | 4 | 6 | no(M2 and SIP pres) | 6 |
6,165 | 62.09399 | 0 | female | 0 | 17 | 1,771 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | null | 0 | 14,936 | 10,613.7734 | 10,445.0469 | 13.333328 | white | 29.398438 | 37 | 0.670898 | 0.575928 | 1 | 0 | 0 | yes | 0.8 | 0.6 | no dnr | 17 | 122 | 13.398438 | 124 | 28 | 37.39844 | 203.3125 | 4.599609 | 1.299805 | 0.399963 | 131 | 7.399414 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
6,166 | 49.10098 | 0 | male | 0 | 42 | 1,769 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 44 | 91,684 | 60,923.8125 | 61,644.8125 | 43.5 | white | 28 | 37 | 0.641968 | 0.540894 | 2 | 0 | 0 | no | 0.85 | 0.85 | no dnr | 42 | 67 | 21.199219 | 126 | 9 | 39.59375 | 177.5 | 2.099609 | 3.5 | 1.399902 | 145 | 7.509766 | null | null | null | null | 0 | SIP>=30 | 0 |
6,167 | 68.14795 | 1 | male | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | under $11k | 0 | 32,717 | 24,427.875 | 24,427.75 | 39.666657 | white | 22.597656 | 36 | 0.792969 | 0.724976 | 3 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 11 | 113 | 17.699219 | 76 | 24 | 38.29688 | 182 | 2.799805 | 1.099854 | 2.599609 | 145 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,168 | 64.87897 | 1 | male | 1 | 6 | 6 | Coma | Coma | 1 | 12 | $25-$50k | 100 | 18,925 | 13,683.5859 | 13,914.7969 | 62 | white | 40.59375 | 78 | 0.001 | 0 | 2 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 6 | 65 | 14.298828 | 180 | 40 | 39.19531 | 146.25 | 2.299805 | 4.399414 | 3.399902 | 130 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 3.17627 |
6,169 | 53.55197 | 0 | male | 0 | 8 | 1,765 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 11 | under $11k | 0 | 19,763 | 15,451.3359 | 15,561.2344 | 26 | white | 29.898438 | 40 | 0.758911 | 0.681885 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 8 | 70 | 10.099609 | 111 | 28 | 38.69531 | 122.84375 | 2.799805 | 2.899902 | 0.599976 | 147 | 7.449219 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,170 | 66.74298 | 0 | female | 0 | 101 | 1,764 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 9 | 156,394 | 114,891.938 | 110,165.125 | 40.25 | white | 25.398438 | 37 | 0.754883 | 0.67688 | 1 | 0 | 0 | no | 0.85 | 0.85 | dnr after sadm | 44 | 71 | 10.898438 | 74 | 24 | 36 | 144.875 | 2.399902 | 2.699707 | 1.599854 | 139 | 7.389648 | null | null | null | 6 | 5 | SIP>=30 | 5 |
6,171 | 19.351 | 0 | male | 0 | 11 | 1,763 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 139,899 | 98,136.8125 | 96,743.875 | 18.5 | white | 31.597656 | 38 | 0.784912 | 0.714966 | 47 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 11 | 71 | 15.898438 | 152 | 30 | 39.59375 | 210 | 3 | 0.5 | 0.299988 | 128 | 7.449219 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
6,172 | 64.85095 | 1 | male | 1 | 58 | 58 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | under $11k | 44 | 214,606 | 147,583.875 | 148,627.875 | 54 | white | 31.5 | 62 | 0.360962 | 0.242981 | 15 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 45 | 67 | 18.296875 | 48 | 28 | 38.19531 | 132.375 | 2.399902 | 2.399902 | 2.599609 | 143 | 7.509766 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,173 | 69.91394 | 1 | male | 0 | 3 | 42 | Lung Cancer | Cancer | 6 | null | under $11k | 0 | 4,052 | 2,795.0059 | 3,625.1582 | 9 | white | 18.398438 | 13 | 0.643921 | 0.335999 | 2 | 0 | 0 | metastatic | null | null | no dnr | 3 | 76 | 8 | 104 | 22 | 36.19531 | null | null | null | 0.799927 | 141 | null | null | null | null | null | 2 | <2 mo. follow-up | 2 |
6,174 | 34.905 | 1 | female | 0 | 4 | 217 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 3,180 | 2,314.9434 | 1,156.22949 | 8 | white | 25.296875 | 22 | 0.843994 | 0.74292 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 4 | 95 | 12.5 | 116 | 24 | 37 | null | 2.5 | 3.599609 | 0.5 | 134 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.290527 |
6,175 | 56.46799 | 1 | male | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 9 | 53,228 | 41,687.2188 | 40,337.5625 | 44.666657 | null | 36.5 | 82 | 0.565918 | 0.454956 | 1 | 0 | 0 | no | 0.15 | 0.15 | dnr after sadm | 17 | 69 | 9.798828 | 138 | 32 | 38.19531 | 186.375 | 1.599854 | 14.599609 | 2.599609 | 133 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 3.189453 |
6,176 | 78.90997 | 1 | female | 1 | 7 | 7 | Coma | Coma | 0 | 5 | null | 61 | 13,488 | 10,996.8281 | 10,169.1094 | 31 | white | 21.199219 | 34 | 0.343994 | 0.270996 | 1 | 0 | 0 | no | 0 | 0 | dnr before sadm | -1 | 122 | 17.699219 | 116 | 20 | 39.09375 | 318 | 2.699707 | 0.399963 | 1.299805 | 151 | 7.399414 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
6,177 | 48.715 | 0 | female | 0 | 28 | 1,759 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | null | 9 | 38,119 | 30,093.0312 | 28,434.8594 | 33.75 | white | 24.796875 | 34 | 0.827881 | 0.768921 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 28 | 61 | 14 | 68 | 26 | 35.29688 | 175 | 2.399902 | 0.599976 | 1.099854 | 151 | 7.229492 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
6,178 | 53.16098 | 1 | female | 1 | 56 | 56 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 0 | 203,235 | 161,786.875 | 153,861.125 | 52.5 | white | 33.09375 | 65 | 0.524902 | 0.409973 | 22 | 1 | 0 | yes | 0.25 | 0.25 | dnr after sadm | 56 | 63 | 19.296875 | 136 | 8 | 36.79688 | 234 | 1.599854 | 7.699219 | 2.799805 | 136 | 7.379883 | null | null | null | null | null | <2 mo. follow-up | 3.276856 |
6,179 | 41.418 | 1 | female | 1 | 7 | 7 | Coma | Coma | 1 | 14 | under $11k | 100 | 25,814 | 20,979.4375 | 19,544.2344 | 48 | black | 25.296875 | 60 | 0.324951 | 0.252991 | 6 | 0 | 0 | no | 0 | 0 | dnr after sadm | 5 | 59 | 16.796875 | 78 | 12 | 35.19531 | 271.375 | 1.5 | 0.599976 | 2.699707 | 133 | 7.279297 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
6,180 | 42.67499 | 1 | female | 1 | 4 | 4 | Coma | Coma | 2 | 12 | under $11k | 100 | 7,940 | 6,883.0859 | 6,103.54688 | 14 | black | 39.5 | 73 | 0.052994 | 0.028 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 2 | 38 | 6.199219 | 153 | 10 | 36.59375 | 387.125 | 3.399902 | 0.799927 | 9 | 144 | 7.189453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,181 | 82.88599 | 1 | male | 1 | 27 | 27 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 44 | 35,067 | 27,143.7344 | 25,166.9531 | 27.25 | white | 20.097656 | 43 | 0.660889 | 0.562988 | 1 | 0 | 0 | no | 0.25 | 0.25 | dnr after sadm | 1 | 66 | 8.898438 | 71 | 12 | 38 | 246 | 2.699707 | 1.299805 | 2.299805 | 157 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 4.868164 |
6,182 | 63.49298 | 0 | male | 0 | 14 | 1,752 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 0 | 28,506 | 22,617.5 | 21,181.6094 | 24 | white | 22.796875 | 36 | 0.827881 | 0.769897 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 14 | 73 | 20.796875 | 114 | 12 | 38.19531 | 208.5625 | 2.199707 | 1.399902 | 1.799805 | 140 | 7.459961 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,183 | 64.41895 | 1 | female | 0 | 22 | 64 | CHF | COPD/CHF/Cirrhosis | 5 | 12 | under $11k | 0 | 38,784 | 31,622.9375 | 29,024.2344 | 36.333313 | white | 31.097656 | 49 | 0.696899 | 0.532959 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 14 | 133 | 8.699219 | 113 | 48 | 36.59375 | 122.5 | 2.699707 | 0.599976 | 0.899902 | 132 | 7.209961 | null | null | null | null | 7 | null | 7 |
6,184 | 38.98398 | 1 | male | 0 | 16 | 425 | MOSF w/Malig | ARF/MOSF | 2 | 14 | under $11k | 0 | 22,489 | 16,593.1719 | 15,599.1328 | 15 | black | 18.398438 | 27 | 0.724976 | 0.639893 | 7 | 1 | 0 | metastatic | 0.75 | 0.5 | no dnr | 16 | 109 | 25.699219 | 108 | 16 | 37.89844 | 434.25 | 1.799805 | 0.599976 | 0.799927 | 139 | 7.449219 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
6,185 | 62.41199 | 1 | female | 1 | 9 | 9 | MOSF w/Malig | ARF/MOSF | 3 | 11 | $11-$25k | 89 | 13,175 | 10,220.5547 | 9,913.67969 | 24.5 | white | 22 | 37 | 0.252991 | 0.148987 | 1 | 1 | 0 | metastatic | 0.05 | 0.000125 | dnr after sadm | 5 | 61 | 20.699219 | 110 | 34 | 39.19531 | 388 | 2.899902 | 1.399902 | 1.299805 | 136 | 7.489258 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,186 | 56.22699 | 1 | female | 0 | 5 | 37 | MOSF w/Malig | ARF/MOSF | 1 | 11 | null | 0 | 15,031 | 10,768.1172 | 10,405.0938 | 23 | black | 19.296875 | 9 | 0.67688 | 0.581909 | 9 | 0 | 0 | metastatic | 0.5 | 0.25 | dnr after sadm | 2 | 81 | 12.599609 | 106 | 24 | 36.5 | 304.75 | 2.799805 | 0.699951 | 1 | 136 | 7.469727 | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
6,187 | 60.82098 | 1 | male | 1 | 4 | 4 | Coma | Coma | 0 | 16 | $25-$50k | 100 | 3,746 | 2,563.1621 | 3,008.18945 | 16 | white | 26.898438 | 52 | 0.17099 | 0.11499 | 1 | 0 | 0 | no | 0.07 | 0.000343 | dnr before sadm | -1 | 127 | 16.796875 | 144 | 10 | 40.39844 | 288 | 3.299805 | 0.399963 | 1.199951 | 130 | 7.489258 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,188 | 59.96997 | 1 | male | 0 | 7 | 55 | Colon Cancer | Cancer | 1 | 7 | under $11k | 0 | 6,863 | 4,849.3125 | 6,283.87891 | 13 | white | 26.5 | 20 | 0.662964 | 0.360962 | 1 | 0 | 0 | metastatic | 0.3 | 0.15 | no dnr | 7 | 77 | 10.798828 | 84 | 22 | 36.79688 | 407.125 | 2.5 | 1.699951 | 0.699951 | 132 | 7.439453 | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
6,189 | 59.63898 | 1 | male | 0 | 12 | 18 | Lung Cancer | Cancer | 3 | 7 | under $11k | 0 | 7,860 | 5,982.418 | 5,864.00781 | 8 | black | 25.796875 | 22 | 0.511963 | 0.189972 | 1 | 0 | 0 | metastatic | 0.2 | 0.05 | dnr before sadm | -1 | 101 | 12.798828 | 56 | 16 | 36.19531 | 890.375 | 2.799805 | 0.299988 | 1.299805 | 158 | 7.419922 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
6,190 | 27.44099 | 0 | male | 0 | 30 | 1,747 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | null | 44 | 62,613 | 45,073.9062 | 45,688.5625 | 29.5 | white | 24.5 | 32 | 0.802979 | 0.737915 | 2 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 30 | 75 | 7.099609 | 126 | 16 | 38.69531 | 157.5 | 1.699951 | 1.799805 | 0.699951 | 135 | 7.379883 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,191 | 76.73895 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 44 | 18,471 | 15,439.2266 | 14,177.1328 | 27 | white | 35.695313 | 74 | 0.243988 | 0.141998 | 2 | 0 | 0 | no | 0.01 | 0.000001 | dnr after sadm | 3 | 72 | 22.199219 | 108 | 44 | 38.19531 | 112.32812 | 1.799805 | 2.599609 | 5.399414 | 146 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 3.124512 |
6,192 | 66.26099 | 0 | female | 0 | 19 | 1,747 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | under $11k | 9 | 20,285 | 15,411.9375 | 16,042.5859 | 17.666656 | black | 22.097656 | 28 | 0.807983 | 0.743896 | 1 | 1 | 0 | no | 0.9 | 0.7 | no dnr | 19 | 112 | 16.199219 | 69 | 16 | 35 | 495.1875 | 2.599609 | 0.299988 | 1.399902 | 151 | 7.349609 | null | null | null | null | 2 | null | 2 |
6,193 | 47.14899 | 1 | male | 0 | 7 | 209 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | 9 | null | 0 | 7,390 | 5,705.2969 | 5,902.97656 | 8.5 | hispanic | 15.699219 | 17 | 0.893921 | 0.821899 | 1 | 0 | 0 | no | 0.75 | 0.7 | no dnr | 7 | 69 | 8.5 | 75 | 20 | 36 | 437.5625 | 3.199707 | 0.799927 | 1.099854 | 134 | 7.489258 | null | null | null | null | null | SIP>=30 | 3.813477 |
6,194 | 51.04199 | 1 | male | 0 | 30 | 944 | MOSF w/Malig | ARF/MOSF | 1 | 14 | >$50k | 0 | 52,045 | 35,465.7812 | 38,358.0312 | 28.5 | white | 32.898438 | 39 | 0.396973 | 0.277954 | 11 | 0 | 0 | yes | 0.7 | 0.3 | no dnr | 30 | 94 | 0 | 104 | 24 | 36.69531 | null | 2.5 | 3.199707 | 1.099854 | 127 | null | null | null | null | null | 0 | SIP>=30 | 0 |
6,195 | 43.49298 | 1 | female | 0 | 7 | 40 | CHF | COPD/CHF/Cirrhosis | 6 | 12 | $11-$25k | 0 | 4,658 | 3,478.6856 | 3,603.80859 | 9 | white | 16.097656 | 16 | 0.934937 | 0.888916 | 1 | 1 | 0 | no | 0.4 | 0.3 | dnr before sadm | -1 | 60 | 8.898438 | 70 | 24 | 36.19531 | null | null | null | 1.199951 | 134 | null | null | null | null | 6 | 5 | <2 mo. follow-up | 5 |
6,196 | 54.63898 | 0 | male | 0 | 55 | 1,745 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $25-$50k | 0 | 19,172 | 40,448.4062 | 36,850.7188 | 19.75 | white | 24.398438 | 22 | 0.834961 | 0.777954 | 1 | 1 | 0 | no | 0.7 | 0.7 | dnr after sadm | 14 | 121 | 16.699219 | 130 | 24 | 36.29688 | 350 | 2.899902 | 0.699951 | 0.699951 | 133 | 7.429688 | null | null | null | null | 6 | null | 6 |
6,197 | 56.48999 | 1 | male | 0 | 3 | 1,383 | Colon Cancer | Cancer | 1 | 11 | $11-$25k | 0 | 1,837 | 1,393.9902 | 1,371.14941 | 13 | black | 13.699219 | 19 | 0.868896 | 0.705933 | 1 | 0 | 0 | metastatic | null | null | no dnr | 3 | 60 | 2.699707 | 70 | 22 | 36.5 | null | 3.699707 | 1.099854 | 0.899902 | 133 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.918701 |
6,198 | 77.63397 | 1 | male | 0 | 72 | 78 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | $11-$25k | 26 | 144,351 | 102,315.188 | 110,045 | 38.75 | white | 25.699219 | 49 | 0.519897 | 0.403992 | 26 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 72 | 65 | 3.5 | 73 | 34 | 38.59375 | 183.21875 | 1.699951 | 2.899902 | 1.699951 | 145 | 7.429688 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
6,199 | 76.03796 | 1 | male | 0 | 4 | 236 | Lung Cancer | Cancer | 2 | null | $25-$50k | 9 | 2,028 | 1,553.627 | 1,575.21973 | 4 | white | 14.398438 | 14 | 0.700928 | 0.414978 | 1 | 0 | 0 | metastatic | 0.2 | 0 | dnr before sadm | -1 | 99 | 3.299805 | 64 | 16 | 36.19531 | null | 3.599609 | 0.399963 | 1.199951 | 136 | null | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
6,200 | 68.48199 | 1 | male | 0 | 7 | 910 | COPD | COPD/CHF/Cirrhosis | 6 | 10 | under $11k | 0 | 11,045 | 8,732.6016 | 8,364.82812 | 31 | white | 25.898438 | 37 | 0.712891 | 0.554932 | 1 | 0 | 0 | yes | 0.75 | 0.7 | no dnr | 7 | 138 | 11.5 | 57 | 12 | 36.79688 | 224.46875 | 3.299805 | 1.099854 | 3 | 140 | 7.389648 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.